These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6794745)

  • 41. Studies on the hypoglycaemic action of gliclazide, a sulphonyl-urea drug [proceedings].
    Furman BL; Musbah MO
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():55P. PubMed ID: 22687
    [No Abstract]   [Full Text] [Related]  

  • 42. [The adhesiveness of platelets and the alteration of retinal capillaries. An experimental study in streptozotocin-induced diabetic rats (author's transl)].
    Kojima K; Harada T; Suzuki M; Awaya S; Ichikawa H
    Nippon Ganka Gakkai Zasshi; 1979 Jun; 83(6):463-71. PubMed ID: 484386
    [No Abstract]   [Full Text] [Related]  

  • 43. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 44. Gliclazide in the treatment of obese non-insulin dependent diabetic patients.
    Seshiah V; Venkataraman S; Suresh K
    J Assoc Physicians India; 1993 Jun; 41(6):367-8. PubMed ID: 8005974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gliclazide (diamicron) in metabolic and vascular treatment of diabetes mellitus.
    Forette B
    East Afr Med J; 1977 Oct; 54(10):579-81. PubMed ID: 608430
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

  • 47. [Gliclazide, a new molecule in the treatment of non-insulin-dependent diabetes mellitus].
    Bour H
    Rev Prat; 1980 Feb; 30(9):593-4. PubMed ID: 7361055
    [No Abstract]   [Full Text] [Related]  

  • 48. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families.
    Mahasandana C; Suvatte V; Püng-amritt P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapeutic value of a new oral antidiabetic agent: gliclazide].
    Bernasconi D; Mazzi C
    Clin Ter; 1978 Mar; 84(6):627-35. PubMed ID: 648108
    [No Abstract]   [Full Text] [Related]  

  • 50. [Does hypoglycemic treatment with gliclazide and gliquidone affect platelet function in type II diabetic patients?].
    Strojek K; Bresler M; Gumprecht J; Grzeszczak W; Trautsolt W
    Pol Arch Med Wewn; 1993 Apr; 89(4):315-9. PubMed ID: 8351232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
    Davis TM; Moore JC; Turner RC
    Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
    Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
    J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Gliclazide in the non-insulin-dependent diabetic patient in geriatrics].
    Frühwald T; Böhmer F
    Wien Med Wochenschr; 1988 Mar; 138(5):102-6. PubMed ID: 3388872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of gliclazide in diabetes: a comparison with tolbutamide.
    Berber MJ; Tomkin GH
    Ir J Med Sci; 1982 Feb; 151(2):46-9. PubMed ID: 7047455
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
    Arfors KE; Bergqvist D; Tangen O
    Ups J Med Sci; 1980; 85(1):74-83. PubMed ID: 7385462
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventive effect of gliclazide on experimental atherosclerosis in rabbits.
    Marquié G
    Diabetologia; 1978 Apr; 14(4):269-75. PubMed ID: 640303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of growth hormone, glucose and insulin on the factor VIII complex.
    Lowe GD; Middleton SM; Hay ID; Beastall GH; Singaraveloo M; Cohen HN; Thomson JA; Forbes CD; Prentice CR
    Thromb Res; 1982 Oct; 28(2):201-11. PubMed ID: 6817455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gliclazide: a general free radical scavenger.
    Scott NA; Jennings PE; Brown J; Belch JJ
    Eur J Pharmacol; 1991 Oct; 208(2):175-7. PubMed ID: 1800127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of the prolonged use of gliclazide in diabetic black Africans (apropos of 51 cases in Dakar)].
    Sankalé M; Signate S; Sow AM; Soumah A
    Dakar Med; 1979; 24(1):127-32. PubMed ID: 498933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.